Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer - PubMed (original) (raw)

Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer

L P Pertschuk et al. Cancer. 1993.

Abstract

Background: It is important to develop parameters that aid in prognosticating which patients with breast cancer are more likely to have a rapid disease course and therefore might benefit from early aggressive therapies.

Methods: Specimens from two groups of women, deliberately selected because their clinical courses differed greatly, were studied to detect amplification of the protooncogenes c-myc, int-2, and C-erbB-2/neu by slot-blot assay, the estrogen receptor (ER), and the progesterone receptor (PR) by both biochemical and immunohistochemical procedures (ERICA and PRICA). One group of 50 patients had a prolonged disease-free interval after initial surgery (mean, 6.4 years); the other group of 52 women had had rapid disease recurrence (mean, 1.4 years) or progression (5 patients died of disease within 1 year of diagnosis). The patients were selected from 1700 consecutively accessioned cases if they fit the study criteria and sufficient tissue was available for oncogene hybridization studies.

Results: The two groups differed statistically by stage, number of involved axillary lymph nodes, ERICA and PRICA results (P = 0.001), and amplification of c-myc (P = 0.003). The percentage of patients with rapid disease recurrence and progression increased from 0-93% when risk factors changed from best case (ERICA and PRICA results, positive; c-myc, not amplified; and axillary nodes, not involved) to worst case (ERICA and PRICA findings, negative; c-myc, amplified; and axillary nodes, involved).

Conclusions: Women with these worst-case parameters were more likely to have a recurrence sooner and rapidly progressive disease. They might benefit from early aggressive therapeutic measures.

PubMed Disclaimer

Cited by

c-MYC promoter G-quadruplex formed at the 5'-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability.
Mathad RI, Hatzakis E, Dai J, Yang D. Mathad RI, et al. Nucleic Acids Res. 2011 Nov 1;39(20):9023-33. doi: 10.1093/nar/gkr612. Epub 2011 Jul 27. Nucleic Acids Res. 2011. PMID: 21795379 Free PMC article.
Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.
Cianchi F, Cortesini C, Fantappiè O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P, Masini E. Cianchi F, et al. Am J Pathol. 2003 Mar;162(3):793-801. doi: 10.1016/S0002-9440(10)63876-X. Am J Pathol. 2003. PMID: 12598314 Free PMC article.
Detection of progesterone receptor forms A and B by immunohistochemical analysis.
Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL. Mote PA, et al. J Clin Pathol. 2001 Aug;54(8):624-30. doi: 10.1136/jcp.54.8.624. J Clin Pathol. 2001. PMID: 11477119 Free PMC article.
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E. Gallo O, et al. Neoplasia. 2001 Jan-Feb;3(1):53-61. doi: 10.1038/sj.neo.7900127. Neoplasia. 2001. PMID: 11326316 Free PMC article.

Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer - PubMed (original) (raw)